
Biocept BIOC
Quarterly report 2023-Q2
added 08-14-2023
Biocept P/CF Ratio 2011-2026 | BIOC
Annual P/CF Ratio Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.447 | 11.2 | -3.37 | -0.269 | -0.234 | -0.44 | -0.87 | -1.53 | -0.562 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.2 | -3.37 | 0.388 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 18.63 | -24.73 % | $ 540 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 17.17 | 0.94 % | $ 181 M | ||
|
Agilent Technologies
A
|
28.3 | $ 117.55 | -0.19 % | $ 35.7 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.25 | 1.48 % | $ 1.13 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.88 | 14.62 % | $ 2.5 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 429.99 | 0.75 % | $ 12.4 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.08 | -0.85 % | $ 378 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.93 | 0.45 % | $ 1.14 B | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 18.09 | 1.26 % | $ 405 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Natera
NTRA
|
-12.3 | $ 212.11 | -1.39 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 187.03 | 2.92 % | $ 9.27 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.29 | 0.33 % | $ 25.9 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 14.91 | -0.07 % | $ 451 M | ||
|
Personalis
PSNL
|
-5.62 | $ 5.87 | -3.28 % | $ 348 M | ||
|
Guardant Health
GH
|
-72.7 | $ 89.38 | -3.11 % | $ 11.2 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.95 | 0.01 % | $ 2.69 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 124.33 | 0.16 % | $ 10.3 B | ||
|
Illumina
ILMN
|
19.6 | $ 137.1 | -3.84 % | $ 21.8 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 5.1 | -4.85 % | $ 213 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 2.04 | -3.33 % | $ 9.02 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.6 | -0.99 % | $ 216 M | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.22 | 0.45 % | $ 5.1 M | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 470.2 | -0.67 % | $ 177 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 92.52 | 7.39 % | $ 6.24 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 57.95 | -2.65 % | $ 3.47 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 257.29 | 0.13 % | $ 21.4 B | ||
|
Celcuity
CELC
|
-35 | $ 129.45 | -7.16 % | $ 6.05 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.17 | -0.11 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 342.29 | -2.15 % | $ 20.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 189.04 | -0.05 % | $ 21 B |